Researchers continue to excited about this new drug, a novel dual agonist showing significant data in clinical trials for weight reduction . It acts by modulating both pathways : GLP-1 and GIP, which , https://marcpops821939.blogoscience.com/47468607/this-new-hope-for-weight-reduction